210 related articles for article (PubMed ID: 33404394)
1. For the patient: COVID-19 vaccines and the public challenges and solutions.
Allergy Asthma Proc; 2021 Jan; 42(1):100. PubMed ID: 33404394
[No Abstract] [Full Text] [Related]
2. The war on infectious diseases: COVID-19 vaccines and the public: Challenges and solutions.
Bellanti JA; Settipane RA
Allergy Asthma Proc; 2021 Jan; 42(1):5-7. PubMed ID: 33357261
[No Abstract] [Full Text] [Related]
3. COVID-19 Vaccine Hesitancy.
Price S
Tex Med; 2021 Jan; 117(1):42-44. PubMed ID: 33641116
[TBL] [Abstract][Full Text] [Related]
4. An Uncertain Public - Encouraging Acceptance of Covid-19 Vaccines.
SteelFisher GK; Blendon RJ; Caporello H
N Engl J Med; 2021 Apr; 384(16):1483-1487. PubMed ID: 33657291
[No Abstract] [Full Text] [Related]
5. Accelerating vaccine trials.
Bull World Health Organ; 2021 Jul; 99(7):482-483. PubMed ID: 34248219
[TBL] [Abstract][Full Text] [Related]
6. How can a global pandemic affect vaccine hesitancy?
Dubé E; MacDonald NE
Expert Rev Vaccines; 2020 Oct; 19(10):899-901. PubMed ID: 32945213
[No Abstract] [Full Text] [Related]
7. US Public Attitudes Toward COVID-19 Vaccine Mandates.
Largent EA; Persad G; Sangenito S; Glickman A; Boyle C; Emanuel EJ
JAMA Netw Open; 2020 Dec; 3(12):e2033324. PubMed ID: 33337490
[TBL] [Abstract][Full Text] [Related]
8. Public preference for COVID-19 vaccines in China: A discrete choice experiment.
Dong D; Xu RH; Wong EL; Hung CT; Feng D; Feng Z; Yeoh EK; Wong SY
Health Expect; 2020 Dec; 23(6):1543-1578. PubMed ID: 33022806
[TBL] [Abstract][Full Text] [Related]
9. Vaccine hesitancy in low- and middle-income countries: potential implications for the COVID-19 response.
Bhopal S; Nielsen M
Arch Dis Child; 2021 Feb; 106(2):113-114. PubMed ID: 32912868
[No Abstract] [Full Text] [Related]
10. Our Best Shot: Texas Physicians Help Find Safe, Effective COVID-19 Vaccines.
Price S
Tex Med; 2020 Nov; 116(11):16. PubMed ID: 33641131
[TBL] [Abstract][Full Text] [Related]
11. Assessing the long-term safety and efficacy of COVID-19 vaccines.
Majeed A; Papaluca M; Molokhia M
J R Soc Med; 2021 Jul; 114(7):337-340. PubMed ID: 33945346
[No Abstract] [Full Text] [Related]
12. Ethical Considerations of Offering Benefits to COVID-19 Vaccine Recipients.
Persad G; Emanuel EJ
JAMA; 2021 Jul; 326(3):221-222. PubMed ID: 34196658
[No Abstract] [Full Text] [Related]
13. A public health timeline to prepare for COVID-19 vaccines in Canada.
MacDonald NE; Comeau J; Dubé E; Bucci L; Graham JE
Can J Public Health; 2020 Dec; 111(6):945-952. PubMed ID: 33151510
[TBL] [Abstract][Full Text] [Related]
14. The COVID vaccine challenges that lie ahead.
Nature; 2020 Nov; 587(7835):522. PubMed ID: 33235368
[No Abstract] [Full Text] [Related]
15. Research on Drugs and Vaccines for COVID-19 Should Be Conducted and Published With Caution.
Chen F; Gong S; Li RQ
J Epidemiol; 2020 Dec; 30(12):574-575. PubMed ID: 33041320
[No Abstract] [Full Text] [Related]
16. Equitable distribution of COVID-19 vaccines.
Burki T
Lancet Infect Dis; 2021 Jan; 21(1):33-34. PubMed ID: 33357392
[No Abstract] [Full Text] [Related]
17. Pharmacies Partner With HHS to Provide COVID-19 Vaccines.
Rubin R
JAMA; 2020 Dec; 324(24):2475. PubMed ID: 33351030
[No Abstract] [Full Text] [Related]
18. Tackling inequitable distribution of the COVID-19 vaccine.
Mendes A
Br J Community Nurs; 2021 Jan; 26(1):48-49. PubMed ID: 33356933
[No Abstract] [Full Text] [Related]
19. Is It Lawful and Ethical to Prioritize Racial Minorities for COVID-19 Vaccines?
Schmidt H; Gostin LO; Williams MA
JAMA; 2020 Nov; 324(20):2023-2024. PubMed ID: 33052391
[No Abstract] [Full Text] [Related]
20. Supporting efforts for a global COVID-19 vaccine.
Gladas K
Br J Nurs; 2021 Jan; 30(1):6. PubMed ID: 33433282
[No Abstract] [Full Text] [Related]
[Next] [New Search]
